An abnormal brain scan or cognitive test result can feel alarming, but it usually does not answer the whole medical question by itself. A scan may show a structural change, an old injury, inflammation, shrinkage, blood vessel changes, or an incidental finding that has little to do with the symptom that led to testing. A cognitive test may show lower-than-expected performance, but the reason can range from sleep loss or depression to medication effects, mild cognitive impairment, dementia, stroke, concussion, seizures, or another medical condition.
The next step is interpretation. Doctors look at the result alongside symptoms, timing, medical history, medications, physical and neurological exam findings, previous test results, and sometimes input from a family member or close observer. In many cases, the follow-up is not one dramatic answer, but a careful process: confirm what the result means, decide whether anything urgent is present, look for reversible contributors, and plan treatment, monitoring, or more specialized testing.
Table of Contents
- What Abnormal Results Usually Mean
- Why Context Changes the Meaning
- Follow-Up After Brain Scan Results
- Follow-Up After Cognitive Test Results
- When Results Need Urgent Care
- Possible Diagnoses and Next Tests
- How to Prepare for Follow-Up
- How Results Shape Care
What Abnormal Results Usually Mean
An abnormal result means the test found something outside the expected range, not necessarily that a person has a severe or permanent condition. The most important question is whether the finding explains the person’s symptoms, needs urgent action, or simply needs monitoring.
“Abnormal” can mean different things depending on the test. A brain MRI might show white matter changes from small blood vessel disease, brain volume loss, a prior silent stroke, a tumor, inflammation, hydrocephalus, or a finding that was not expected but may be unrelated. A CT scan might show bleeding, a stroke, a fracture after injury, a mass effect, or age-related changes. PET scans may show patterns of metabolism or amyloid/tau activity that can support certain dementia evaluations. Cognitive tests may show difficulties with memory, attention, language, visual-spatial skills, processing speed, or executive function.
The word abnormal also depends on the comparison point. A mild finding in a healthy 78-year-old may have a different meaning than the same finding in a 38-year-old with rapidly worsening symptoms. A lower cognitive score may be more concerning if it represents a clear decline from a person’s usual abilities, especially if it affects work, finances, driving, medication management, or daily routines.
| Result type | What it may suggest | What doctors usually clarify next |
|---|---|---|
| Unexpected MRI or CT finding | Structural change, old injury, bleeding, mass, stroke, fluid buildup, inflammation, or incidental finding | Whether it is new, urgent, symptom-related, or needs repeat imaging |
| Abnormal PET scan | Changes in brain metabolism or disease-related biomarkers | Whether the pattern fits the symptoms and whether further biomarker testing is needed |
| Low cognitive screening score | Possible cognitive impairment, but also possible effects of mood, sleep, language, hearing, education, medications, or illness | Whether the result reflects true decline and whether fuller testing is needed |
| Abnormal neuropsychological profile | Pattern of strengths and weaknesses across cognitive domains | Which brain systems are affected and how results match daily functioning |
A normal result also has limits. Some conditions do not show clearly on routine imaging, and some people with early cognitive symptoms can score within the normal range on brief screening tests. That is why clinicians interpret results as part of a larger workup rather than treating a single scan or score as the full answer.
Why Context Changes the Meaning
The same abnormal result can mean very different things depending on symptoms, timing, age, medical history, and the type of test used. A result that looks serious in one situation may be expected or low-risk in another.
Doctors usually start by asking why the test was ordered. A scan done after sudden weakness, speech trouble, seizure, head injury, or severe headache is interpreted with urgency. A scan done for slowly progressive memory concerns is read in a different clinical frame. A cognitive test done during an infection, after poor sleep, or during intense anxiety may need to be repeated when the person is medically stable.
Several factors can affect cognitive test performance without meaning that a person has dementia or permanent brain damage:
- Poor sleep, untreated sleep apnea, jet lag, or shift work
- Depression, anxiety, grief, trauma symptoms, or high stress
- Pain, fatigue, infection, dehydration, or recent hospitalization
- Alcohol, cannabis, sedating medicines, anticholinergic medicines, opioids, or medication interactions
- Hearing or vision problems that interfere with instructions
- Language differences, low literacy, limited formal education, or unfamiliar testing format
- Recent concussion, seizure, migraine, or delirium
This is especially important for brief screening tools. A low MoCA, MMSE, Mini-Cog, or similar score can point toward the need for more evaluation, but it is not a diagnosis by itself. For a closer look at how common screening scores are interpreted, see MoCA, MMSE, and Mini-Cog score interpretation.
Brain scan results also need context. Mild white matter changes are common with age and vascular risk factors such as high blood pressure, diabetes, smoking, and high cholesterol. Brain volume loss may be described as “atrophy,” but the degree, pattern, and change over time matter. A small benign-appearing cyst or vascular variant may be mentioned in a report even if it does not explain symptoms.
Clinicians also compare new results with old ones when possible. A stable finding that has not changed for years is often less concerning than a new or enlarging finding. A cognitive score that is slightly low but unchanged over several years means something different from a score that has clearly declined over 6 to 12 months.
The practical question is not simply “Is it abnormal?” but “Is it clinically meaningful?” A meaningful result changes the next step: urgent care, a specialist referral, additional testing, treatment, safety planning, or repeat monitoring.
Follow-Up After Brain Scan Results
After an abnormal brain scan, the usual next step is to review what was found, whether it explains the symptoms, and whether it requires urgent treatment, specialist input, or follow-up imaging. The radiology report is important, but the treating clinician connects the report to the person’s actual condition.
A brain scan report often uses technical language. Words such as lesion, hyperintensity, atrophy, ischemic change, calcification, enhancement, mass effect, microhemorrhage, or ventriculomegaly can sound frightening. Some are serious. Others are descriptive terms that need clinical interpretation. Asking the clinician to translate the report into plain language is reasonable and often necessary.
For MRI findings, doctors may discuss the brain region involved, whether contrast was used, whether diffusion imaging suggests a recent stroke, whether there are signs of inflammation or demyelination, and whether the pattern fits the symptoms. A broader explanation of what MRI can and cannot show is available in this article on what a brain MRI shows.
For CT findings, the follow-up depends heavily on why the CT was ordered. CT is often used when speed matters, such as suspected bleeding, stroke, trauma, or sudden neurological change. It can also be used when MRI is not available or is unsafe because of certain implants or other factors. This overview of what a brain CT scan can detect gives more context for common CT uses.
Possible follow-up steps after abnormal imaging include:
- Clinical review of the report. The ordering clinician explains the finding, how confident the interpretation is, and whether it matches the symptoms.
- Comparison with prior imaging. Older scans can show whether the finding is new, stable, growing, or improving.
- Repeat imaging. A repeat MRI, CT, or specialized scan may be ordered if the finding is unclear or needs monitoring.
- Additional imaging technique. This may include MRI with contrast, MR angiography, CT angiography, PET, or another targeted study.
- Laboratory testing. Blood tests may look for infection, inflammation, vitamin deficiency, thyroid problems, autoimmune disease, metabolic issues, or vascular risk factors.
- Specialist referral. A neurologist, neurosurgeon, neuroradiologist, psychiatrist, neuropsychologist, or memory clinic may become involved depending on the finding.
- Treatment or risk reduction. Stroke prevention, seizure management, blood pressure treatment, medication changes, surgery, infection treatment, or cognitive care planning may be considered.
Brain imaging for memory loss deserves special care. MRI or CT can help identify strokes, tumors, normal pressure hydrocephalus, subdural bleeding, and patterns of atrophy, but imaging alone usually does not diagnose most dementia syndromes. PET scans and biomarkers may add information in selected cases. For a more focused discussion, see brain imaging for memory loss.
If the scan report says “incidental finding,” that does not mean it should be ignored. It means the finding was not necessarily what the doctor was looking for. Some incidental findings need no action, some need repeat imaging, and some need a specialist opinion.
Follow-Up After Cognitive Test Results
After abnormal cognitive test results, the next step is to determine whether the result reflects true cognitive decline, a temporary effect, a mental health condition, a medical problem, or a specific neurocognitive disorder. A low score is a signal to investigate, not a final diagnosis.
Brief cognitive screening tests are designed to flag possible problems. They are often used in primary care, neurology, geriatrics, memory clinics, hospitals, and sometimes occupational or rehabilitation settings. They can be useful, but they are limited. A person may score poorly because of anxiety, poor hearing, low vision, unfamiliar language, fatigue, low education, or pain. Another person may score well on a short screen despite real-world problems with planning, work performance, finances, or complex daily tasks.
When cognitive screening is abnormal, doctors usually ask about daily function. This matters because cognitive impairment is not defined only by test performance. Clinicians want to know whether changes are affecting:
- Remembering appointments, conversations, medications, or bills
- Managing finances, work tasks, cooking, shopping, or transportation
- Finding words, following conversations, or understanding instructions
- Navigating familiar places
- Making decisions, organizing steps, or solving problems
- Personality, judgment, mood, motivation, or social behavior
- Driving safety, falls, wandering, or vulnerability to scams
A fuller neuropsychological evaluation may be recommended when the diagnosis is unclear, the person is younger, symptoms are subtle, work or school functioning is affected, or there is a need to separate memory problems from attention, mood, language, learning, or executive function issues. Neuropsychological testing looks at patterns, not just one score. A detailed guide to neuropsychological test score meaning can help clarify terms such as percentile, standard score, impairment, validity, and cognitive domain.
Doctors may also order blood tests after abnormal cognitive results. Common labs can check for anemia, thyroid disease, vitamin B12 deficiency, folate deficiency, kidney or liver problems, blood sugar abnormalities, electrolyte problems, inflammation, infections when relevant, and medication-related issues. This is especially common when symptoms include brain fog, fatigue, mood changes, confusion, or memory loss. For more detail, see blood tests used in memory-loss workups.
Abnormal cognitive results are sometimes followed over time. A repeat test can show whether performance is stable, improving, or declining. Stability may suggest a longstanding learning profile, ADHD, mood-related effects, or a non-progressive injury. Improvement may occur after treating sleep apnea, depression, medication side effects, thyroid disease, vitamin deficiency, alcohol-related effects, or post-concussion symptoms. Decline over time may point toward a progressive neurological condition and usually deserves more specialized evaluation.
When Results Need Urgent Care
Some abnormal scan or cognitive results need prompt or emergency evaluation, especially when symptoms are sudden, severe, or rapidly worsening. Do not wait for a routine follow-up visit if new neurological or mental status symptoms suggest a possible emergency.
Seek urgent or emergency care for symptoms such as:
- Sudden weakness, numbness, facial drooping, vision loss, trouble speaking, or trouble understanding speech
- New confusion, severe disorientation, or sudden inability to stay awake
- A first seizure, repeated seizures, or a seizure with injury or prolonged confusion
- Sudden “worst headache,” especially with vomiting, neck stiffness, fainting, or neurological symptoms
- Head injury followed by worsening headache, repeated vomiting, confusion, weakness, seizure, or unusual behavior
- New loss of balance, severe dizziness with neurological symptoms, or inability to walk safely
- Fever with confusion, stiff neck, severe headache, or new neurological symptoms
- Rapid personality change, hallucinations, delusions, severe agitation, or unsafe behavior
- Suicidal thoughts, threats of self-harm, or concern that someone may harm others
A result can also become urgent because of what the report shows. Examples include bleeding in or around the brain, a mass causing pressure, signs of acute stroke, hydrocephalus with concerning symptoms, infection, severe inflammation, or rapidly progressive changes. In those cases, the ordering clinician or radiology team may contact the patient directly, send the person to the emergency department, or arrange urgent specialist care.
Cognitive symptoms can be urgent too. Sudden confusion is not the same as gradual forgetfulness. Delirium, medication toxicity, infection, low oxygen, abnormal blood sugar, dehydration, alcohol or drug effects, and metabolic problems can cause abrupt changes in attention and awareness. Older adults are especially vulnerable, and delirium can fluctuate through the day.
There are also urgent mental health situations that may occur alongside abnormal cognitive or brain-related findings. Severe depression with suicidal thoughts, psychosis, mania, extreme agitation, or inability to care for basic needs should be treated as urgent. More detail is available in this guide on when to go to the ER for mental health or neurological symptoms.
If a person receives an abnormal result through an online portal before the doctor has called, it is reasonable to contact the ordering office and ask how quickly the result needs review. If the symptoms are severe or sudden, emergency care is safer than waiting for a callback.
Possible Diagnoses and Next Tests
Abnormal results can point toward many different explanations, so the follow-up depends on the pattern rather than the word abnormal alone. Doctors usually work through categories: urgent causes, reversible contributors, structural brain disease, neurodegenerative disease, psychiatric conditions, sleep disorders, medication effects, and functional impact.
Common possibilities include mild cognitive impairment, Alzheimer’s disease, vascular cognitive impairment, Lewy body dementia, frontotemporal dementia, normal pressure hydrocephalus, prior stroke, traumatic brain injury, seizure disorders, multiple sclerosis or other inflammatory conditions, brain tumors, infections, autoimmune disease, metabolic disorders, depression, anxiety, sleep apnea, substance-related cognitive changes, and medication side effects.
The next test is chosen to answer a specific question. More testing is not always better. A useful test should clarify diagnosis, change management, estimate risk, guide treatment, or help with planning.
Examples of targeted follow-up include:
- MRI after CT when more detail is needed about tissue, old injury, inflammation, tumors, small strokes, or atrophy patterns.
- Vascular imaging when stroke, blood vessel narrowing, aneurysm, or vascular malformation is suspected.
- EEG when seizures, episodes of altered awareness, or certain encephalopathies are possible.
- Lumbar puncture when infection, inflammation, certain autoimmune conditions, or cerebrospinal fluid biomarkers are being considered.
- Amyloid or tau PET in selected dementia evaluations when knowing Alzheimer’s-related pathology would change diagnosis or treatment planning.
- Blood-based Alzheimer’s biomarkers in specialized care settings when appropriate, usually as part of a broader evaluation rather than as a stand-alone answer.
- Sleep testing when snoring, witnessed pauses in breathing, excessive daytime sleepiness, morning headaches, or resistant brain fog suggests sleep apnea.
- Psychiatric or psychological evaluation when mood, anxiety, trauma, psychosis, ADHD, or personality changes may explain or contribute to symptoms.
Who interprets the findings also matters. Primary care clinicians often coordinate the first stage of evaluation and rule out common medical contributors. Neurologists evaluate nervous system causes. Geriatricians often help with complex older-adult cases. Psychiatrists evaluate mood, psychosis, medication effects, and mental health conditions. Neuropsychologists perform detailed cognitive testing and explain patterns of performance. This comparison of psychiatrists, psychologists, and neuropsychologists explains how these roles differ.
Sometimes the answer is mixed. A person may have mild Alzheimer’s disease plus vascular changes, depression plus sleep apnea, ADHD plus anxiety, or prior concussion plus medication side effects. Mixed explanations are common, especially in older adults or people with several medical conditions. A careful workup should not stop at the first abnormal finding if it does not fully explain the symptoms.
How to Prepare for Follow-Up
Preparing for the follow-up visit helps the clinician connect the abnormal result to real-life symptoms and decide what to do next. Bring the result, but also bring the story behind it.
If possible, write down when symptoms began, whether they were sudden or gradual, and how they have changed. Note whether symptoms fluctuate during the day, worsen with stress or poor sleep, or appeared after a medication change, infection, injury, surgery, pregnancy, menopause transition, major stressor, or substance use change.
It is often helpful to bring a trusted person to the appointment, especially for memory or behavior concerns. Family members or close friends may notice changes the patient does not see, such as repeated questions, missed bills, unsafe driving, personality changes, confusion with technology, or difficulty following conversations. Their role is not to speak over the patient, but to add observations that help the clinician understand daily function.
Bring or prepare:
- A current medication and supplement list, including doses and recent changes
- Copies of prior MRI, CT, PET, EEG, lab, or cognitive test reports if available
- Information about alcohol, cannabis, sedatives, sleep aids, or recreational drug use
- A timeline of symptoms and major health events
- Notes about sleep, snoring, daytime sleepiness, mood, anxiety, pain, and fatigue
- Examples of daily-life problems, not just general statements such as “memory is worse”
- Questions about urgency, diagnosis, treatment, restrictions, and follow-up timing
Good questions to ask include:
- What exactly was abnormal, and how confident is the finding?
- Does this result explain the symptoms, or could it be incidental?
- Is anything urgent or dangerous?
- Do we need to compare this with prior results?
- What conditions are still being considered?
- Are there reversible causes we should check?
- Should any medications be changed or reviewed?
- Do I need a neurologist, neuropsychologist, psychiatrist, memory clinic, or another specialist?
- When should testing be repeated?
- What symptoms should prompt urgent care before the next appointment?
Ask for a copy of the report and a plain-language explanation. If the report uses a term such as atrophy, ischemic change, lesion, microvascular disease, or impaired executive function, ask what it means in this specific case. The same word can carry different levels of importance depending on severity and context.
It is also reasonable to ask what the result does not show. For example, a normal MRI does not rule out all causes of cognitive symptoms. A low cognitive score does not prove dementia. A positive biomarker may support a disease process but still needs to be interpreted with symptoms and functioning. Knowing the limits of the test can reduce confusion and prevent overconfidence in a single result.
How Results Shape Care
The purpose of follow-up is not only to name the abnormality, but to decide what care is needed now and what should be watched over time. Results may lead to treatment, prevention, rehabilitation, safety planning, or reassurance with monitoring.
If a reversible or treatable contributor is found, care may focus on correcting it. Examples include changing a medication that affects thinking, treating sleep apnea, addressing thyroid disease or vitamin B12 deficiency, improving blood pressure or diabetes control, treating depression or anxiety, reducing alcohol use, managing seizures, or treating infection or inflammation. Improvement may take weeks or months, and repeat testing may be needed to confirm recovery.
If results suggest a neurological disorder, care may include medication, rehabilitation, risk reduction, and specialist monitoring. Stroke-related findings may lead to vascular risk management. Seizure-related findings may lead to antiseizure treatment. Normal pressure hydrocephalus may require neurology and neurosurgery evaluation. A tumor or mass may need urgent or planned specialty care depending on type, size, growth, and symptoms.
If the concern is mild cognitive impairment or dementia, care usually includes more than diagnosis. Clinicians may discuss driving, work, finances, home safety, medication management, exercise, sleep, hearing and vision, social support, advance care planning, and caregiver needs. Some people may be candidates for disease-specific treatments, but eligibility depends on diagnosis, stage, biomarkers, risks, other medical conditions, and access to specialty monitoring.
Newer Alzheimer’s-related blood biomarker tests and PET scans can be useful in selected patients, especially when the result would change diagnosis or treatment decisions. They are not meant to replace a clinical evaluation, and they are not generally used as casual screening tests for people without symptoms. False positives, false negatives, and uncertain results can occur, so interpretation should be done by clinicians familiar with cognitive disorders and biomarker limitations.
Monitoring is common. A clinician may repeat cognitive testing in 6 to 12 months, repeat imaging after a defined interval, or track symptoms and daily function. Follow-up is especially important when the diagnosis is uncertain, symptoms are progressing, or a result could change management over time.
Care should also address the emotional impact of abnormal results. People may feel fear, embarrassment, anger, grief, or relief that symptoms are being taken seriously. Families may disagree about what the changes mean. A clear plan can help: what is known, what is uncertain, what will be tested next, what can be treated now, what would count as worsening, and who to contact with concerns.
An abnormal result is best viewed as a decision point, not the end of the story. The safest and most useful next step is a careful clinical review that connects the result to the person’s symptoms, risks, goals, and day-to-day life.
References
- New Clinical Practice Guideline on the Process for Diagnosing Alzheimer’s Disease or a Related Form of Cognitive Impairment or Dementia 2024 (Guideline Summary)
- ACR Appropriateness Criteria® Dementia: 2024 Update 2025 (Guideline)
- Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup 2025 (Appropriate Use Criteria)
- Revised criteria for diagnosis and staging of Alzheimer’s disease 2024 (Criteria)
- FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease 2025 (Regulatory Update)
- Dementia: assessment, management and support for people living with dementia and their carers 2018 (Guideline; last reviewed 2025)
Disclaimer
This article is for general educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Abnormal brain scan or cognitive test results should be reviewed with a qualified healthcare professional who can interpret them in the context of symptoms, medical history, medications, and exam findings. Seek urgent care for sudden neurological symptoms, severe confusion, seizures, head injury with worsening symptoms, or any immediate safety concern.
If this article was helpful, consider sharing it on Facebook, X, or another platform where it may help someone preparing for a follow-up appointment.
